Portfolio company
Everna
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops stem cell models and therapeutic drugs to treat age-related neurodegenerative and cardiovascular diseases for the medical industry.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
EverZom
The company develops exosome-based regenerative therapies and a biomanufacturing platform for pharmaceutical laboratories, biotechnology firms, and cosmetics companies.
Averna Therapeutics
This biotechnology company develops genomic medicines using RNA-based technology to insert therapeutic genes into safe genomic locations for patients with various diseases.
ReproGo
This regenerative medicine company develops stem cell-derived vascular cells and organoids for drug screening and treating chronic wounds and cardiovascular diseases.
VascVersa Ltd
This company develops vascular cell therapies to regenerate blood vessels for patients with ischaemic diseases, chronic wounds, and retinal vascular conditions.
Souvien Therapeutics
This biotechnology company develops therapeutic agents targeting epigenetic mechanisms to treat neurodegenerative diseases for patients with age-related conditions like dementia.
Altos Labs
This biotechnology company develops cellular rejuvenation therapies to restore cell health and reverse diseases for patients with chronic illnesses and age-related disabilities.
Elevian
This biotechnology company develops regenerative medicines targeting the GDF11 pathway to treat stroke and age-related diseases for patients.
Talisman Therapeutics
The company develops human stem cell models of neurodegenerative diseases to provide drug discovery and target validation services for biotechnology and pharmaceutical organisations.
